Please assess the completion status of the following clinical trial:

Trial Title: Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* history of two or more unexplained consecutive pregnancy losses prior to 32 weeks~* presence of one of the panel of autoantibodies/thrombophilia markers~* confirmed pregnancy~Exclusion Criteria:~* SLE~* known peptic ulcer disease~* sensitivity to ASA or heparin~* previous thrombotic event~* geographic distance from clinic~* failure to consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 44 Years
- Healthy Volunteers: f

Study Arms:
- a (Type: EXPERIMENTAL): None
- b (Type: ACTIVE_COMPARATOR): Low dose aspirin only

Based on this trial design, predict the completion outcome and termination type (if applicable).